| Titolo |
Pubblicato in |
Anno |
| Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience |
NEUROTHERAPEUTICS |
2024 |
| Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod |
JOURNAL OF NEUROLOGY |
2024 |
| Telerehabilitation and onsite rehabilitation effectively improve quality of life, fatigue, balance, and cognition in people with multiple sclerosis: an interventional study |
FRONTIERS IN NEUROLOGY |
2024 |
| Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off |
SCIENTIFIC REPORTS |
2024 |
| Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy |
MULTIPLE SCLEROSIS |
2024 |
| Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS |
BMC NEUROLOGY |
2024 |
| Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2024 |
| Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEG |
NEUROBIOLOGY OF DISEASE |
2023 |
| Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression |
JOURNAL OF CLINICAL MEDICINE |
2023 |
| Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2023 |
| Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D |
CLINICAL AND TRANSLATIONAL NEUROSCIENCE |
2023 |
| Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case report |
FRONTIERS IN NEUROLOGY |
2023 |
| No Changes in Functional Connectivity After Dimethyl Fumarate Treatment in Multiple Sclerosis |
NEUROLOGY AND THERAPY |
2022 |
| Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes? |
BIOMEDICINES |
2022 |
| SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study |
MULTIPLE SCLEROSIS |
2022 |
| Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS) |
NEUROLOGICAL SCIENCES |
2022 |
| Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study |
NEUROLOGY AND THERAPY |
2022 |
| Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy |
FRONTIERS IN NUTRITION |
2022 |
| Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with natalizumab: a multicenter, observational study |
NEUROLOGICAL SCIENCES |
2022 |
| Experiencing Forest Therapy in the Italian Landscape: Bathing in the Selva of Castelfidardo |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
2022 |
